Search

Your search keyword '"Britton, KE"' showing total 290 results

Search Constraints

Start Over You searched for: Author "Britton, KE" Remove constraint Author: "Britton, KE"
290 results on '"Britton, KE"'

Search Results

2. Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG]

4. Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide

5. Can the estimation of ejection fraction during gated single photon emission computed tomography at rest add information to the cardiac perfusion study?

6. Immunotechnological trends in radioimmuno targeting

8. Imaging the adrenal cortex

14. The optimization of nuclear medicine procedures for the diagnosis and management of thyroid disorders in developing countries

15. A Brief Guide to the Practice of Radioimmunoscintigraphy and Radioimmunotherapy in Cancer

17. Annual subscriptions

21. Privacy and Security Issues Surrounding the Protection of Data Generated by Continuous Glucose Monitors.

22. 99mTc-interleukin-2 scintigraphy in normal subjects and in patients with autoimmune thyroid diseases: a feasibility study.

23. International Scientific Committee of Radionuclides in Nephrourology (ISCORN) consensus on renal transit time measurements.

24. Differential diagnosis of adnexal masses: risk of malignancy index, ultrasonography, magnetic resonance imaging, and radioimmunoscintigraphy.

25. The management of differentiated thyroid cancer using 123I for imaging to assess the need for 131I therapy.

26. The prospective clinical and scintigraphic assessment of patients with preserved left ventricular systolic function after transmyocardial laser revascularisation.

27. Imaging with radiolabelled monoclonal antibody (MUJ591) to prostate-specific membrane antigen in staging of clinically localized prostatic carcinoma: comparison with clinical, surgical and histological staging.

28. Radioimmunotherapy. Progress, potential and problems.

29. Radioimmunotherapy of Non-Hodgkin's lymphoma.

31. Tositumomab and iodine I 131 tositumomab for recurrent indolent and transformed B-cell non-Hodgkin's lymphoma.

32. Elimination of the influence of total renal function on renal output efficiency and normalized residual activity.

33. [Clinical outcome of patients after transmyocardial laser revascularization alone and combined with coronary artery bypass grafting].

34. Should high hTg levels in the absence of iodine uptake be treated?

35. Radioimmunoscintigraphy with Tc-99m-labelled SM3 in differentiating malignant from benign adnexal masses.

37. Neuro-otological findings in Pendred syndrome.

38. 123I-Interleukin-2: biochemical characterization and in vivo use for imaging autoimmune diseases.

39. Left ventricular function assessed by gated spet after an exercise-augmented adenosine infusion. Correlation with myocardial ischaemia.

40. (99m)Tc-ciprofloxacin scintigraphy in rabbit model of prosthetic joint infection.

41. Is deconvolution applicable to renography?

42. Infection is not specific for bacterial osteo-articular infective pathology.

43. The comparison of two gated SPET protocols: adenosine Tc-99m tetrofosmin and treadmill exercise Tc-99m MIBI.

44. Imaging bacterial infection with (99m)Tc-ciprofloxacin (Infecton).

45. Can the estimation of ejection fraction during gated single photon emission computed tomography at rest add information to the cardiac perfusion study?

47. Ocular metastases secondary to carcinoid tumors: the utility of imaging with [(123)I]meta-iodobenzylguanidine and [(111)In]DTPA pentetreotide.

48. Axillary node status in breast cancer patients prior to surgery by imaging with Tc-99m humanised anti-PEM monoclonal antibody, hHMFG1.

50. The role of 123I-diagnostic imaging in the follow-up of patients with differentiated thyroid carcinoma as compared to 131I-scanning: avoidance of negative therapeutic uptake due to stunning.

Catalog

Books, media, physical & digital resources